Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class ...
“Our test identifies very early stages of tau tangle formation — up to a decade before any tau clumps can show up on a brain scan,” said senior study author Thomas Karikari, an assistant ...
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
A short bout of indulgence in fatty, sugary snacks leads to lingering brain-activity changes ― even if it does not cause ...
Scientists found brainstem neurons that tell mice when to stop eating, offering insights for obesity treatments. Columbia ...
6h
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
A recent study investigated muscle function in people with hip ... Ultra-Powered MRI Scans Show Damage to Brain's 'Control Center' Is Behind Long-Lasting COVID-19 Symptoms Oct. 8, 2024 — Damage ...
The combination of targeting these two receptors instead of one ... “We now know that targeting the brain is a good way of actually tackling obesity,” says Giles Yeo, a molecular geneticist ...
By targeting a specific subunit of NMDA receptors, they successfully reduced excessive protein synthesis in the brain, a hallmark of the disorder. Their approach, tested in fragile X model mice, not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback